Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07082231 Sponsor: University Hospital, Bordeaux Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07082231
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are covered by a social security system.
  • People who speak French.
  • People who are 18 years of age or older.
  • People who have given their free, informed, and written agreement to participate before the trial begins.
  • People who have been diagnosed with ulcerative colitis (a type of inflammatory bowel disease affecting the large intestine) according to recognised European guidelines.
  • People who are scheduled to have a camera examination of the lower bowel or surgery on the colon or rectum.
  • People without ulcerative colitis who are scheduled to have a bowel camera examination that includes removal of certain types of growths in the bowel, specifically hyperplastic polyps in the rectum, sessile serrated lesions, or adenomas larger than 2 cm.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have lesions around the anal area or in the small intestine, or whose bowel examination shows signs that may suggest Crohn's disease (a related but different bowel condition).
  • People who are pregnant or breastfeeding.
  • People who are under legal protection or who are not able to give informed consent on their own.
  • People who are detained or held under a court or government order, hospitalised without their consent, or living in a healthcare or social care facility for reasons unrelated to this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pauline RIVIERE, MD, University Hospital, Bordeaux

Phone: +335 57 65 64 39

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Mayo clinical activity score; UCEIS endoscopic activity score; Nancy histological activity score; Advanced therapy (biologics or small molecules); Hospitalization due to disease flare; Colectomy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov